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Abstract: In the present study, rainbow trout weighting 3±0.3 g were vaccinated with an oral DNA 
vaccine encoding VP2 gene of a prevalent isolate of IPNV in Iranian trout farms encapsulated in 
sodium alginate microspheres and Chitosan tripolyphosphate (CS/TPP) nanoparticles. The 
vaccinated fish were then challenged with a virulent isolate of IPNV at 30 days post-vaccination. The 
transcriptional changes of adaptive- immune genes (IgM and IgT), as well as the  VP4 gene of IPNV, 
as an indicators of viral replication were studied 45 days post-challenge. Analysis of RT-qPCR data 
showed lower levels of VP4 gene expression in the oral DNA vaccinated trout after IPNV challenge 
compared with the control one. Moreover, the constructed DNA vaccine did not enhance the 
expression of IgM and IgT genes above the levels observed in the carrier control group but it showed 
a mimic of viral activity and contributes to maintaining them at appreciable levels in vaccinated 
group. 
  
Introduction 
Infectious pancreatic necrosis (IPN) is an important 
viral disease of both salmonid and non-salmonid 
fishes caused by infectious pancreatic necrosis Virus 
(IPNV) belonging to the family Birnaviridae, and 
genus Aquabirnavirus (Dobos, 1977; Reno, 1999; 
Rodriguez Saint-Jean et al., 1991). This virus 
contains a bisegmented genome (A and B) of double-
stranded RNA with segment A being larger 
(approximately 3.1 kbp) encoding VP2 that the most 
of viral neutralizing epitopes are mapped to it 
(Tarrab et al., 1993; Frost et al., 1995; Hill and Way, 
1995; Fridholm et al., 2007). IPNV infects both fry 
and juveniles of Atlantic salmon, brook trout and 
rainbow trout resulting in high morbidity and 
mortality (Evensen, 2008). The surviving fish may 
become asymptomatic carriers shedding virus via 
urine, feces and reproductive products (Rodriguez 
Saint-Jean et al., 1991; Johansen and Sommer, 
1995).  
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After many researches still need to an appropriate 
vaccine against IPNV with a long lasting protection 
especially at an early age and preventing the carrier 
formation is crucial. However, different antigen 
delivery systems, including live, inactivated whole 
virus, fusion protein, subunit, virus-like particles, 
and intramuscular DNA vaccines have been 
investigated (Munang’andu and Evensen, 2015). 
Oral DNA vaccines are considered as a new strategy 
and ideal way to immunize large numbers of small 
fish against IPNV (Hølvold et al., 2014). DNA 
vaccines are plasmid DNAs encoding specific 
proteins that can be expressed in cells of an 
inoculated host, inducing strong and long-lasting 
humoral and cellular immune responses. Intra-
muscular injection is an effective common route of 
DNA vaccination in fishes. Also, some antigen-
encapsulation methods have been approved for oral 
delivery of such vaccines (Bozkir and Saka, 2004; de 
las Heras et al., 2010). However, the mechanisms 
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responsible for protection of this delivery system are 
not completely clarified.  
Iran is one of the leading countries in trout 
farming which its production remarkably decreased 
due to viral disease outbreaks such as IPN (Soltani et 
al., 2015). In the present study, we assessed 
transcriptional changes of adaptive- immune genes 
(IgM and IgT), as well as the VP4 gene of IPNV in 
vaccinated rainbow trout with an oral DNA vaccine 
encoding VP2 gene of a prevalent isolate of IPNV in 
Iranian trout farms encapsulated in sodium alginate 
microspheres and chitosan tripolyphosphate (CS/ 
TPP) nanoparticles. Hence, the trout were 
challenged with a virulent IPNV at 30 days post-
vaccination and then the transcript change of 
mentioned genes measured in the survived fish at 45 
days after challenge. 
 
Materials and Methods 
Construction and preparation of the DNA vaccine: 
The VP2 gene of a prevalent isolate of IPNV in 
Iranian trout farms, cultured in CHSE-214 cell line, 
was cloned into a eukaryotic expression vector 
pcDNA3.1 (Invitrogen, USA) under the control of 
the immediate-early cytomegalovirus (CMV) pro-
moter, yielding pcDNA3.1-VP2. The pcDNA3.1-
VP2 was verified using Hind III and Xho I 
endonuclease analysis and the recombinant plasmid 
was then amplified in Escherichia coli (TOP10), and 
the cells were grown in LB broth with ampicillin 
(Fig. 1). The plasmid DNA was isolated with the 
Endofree Plasmid Mega purification Kit (Qiagen, 
USA) according to the manufacturer’s instructions. 
The DNA concentration was measured in a spectro-
photometer (NanoDrop 2000, Thermo scientific, 
Spain) before it was aliquoted, and stored at -20°C 
until use. 
Encapsulation of DNA vaccine (pcDNA3.1-VP2): 
The pcDNA3.1-VP2 and pcDNA3.1 plasmids were 
encapsulated in sodium alginate microspheres and 
CS/TPP nanoparticles as described by Bozkir and 
Saka (2004) and de las Heras et al. (2010), and 
lyophilized and stored at 4ºC. Briefly, an equal 
volume of heated CS/TPP (prepared by ionic 
gelation process; Vimal et al., 2012) and pcDNA3.1-
VP2 solutions was quickly mixed together and 
vortexed at 2500 rpm for 30 s. The pcDNA3.1-VP2 
loaded CS/TPP particles were separated by 
centrifugation at 20,000 rpm for 30 min at 10°C.  
For preparation of microspheres, 1.5 mL of 
pcDNA-VP2 (1 mg ml-1) were mixed with 2.5 mL of 
sodium alginate (3% w/v), then the mixture after 
stirrer (10 min at 500 rpm) was emulsified (30 min 
at 900 rpm) with Span 80 (0.5 mL) and paraffin oil 
(100 mL). A volume of 2.5 ml of 0.15M CaCl2 was 
then added to emulsion and stirred (900 rpm for 2 
hrs). Microspheres were collected by centrifugation 
(10 min at 1000 g) and washed with ethanol (70%). 
The unbound pcDNA-VP2 content in the 
supernatant was quantified by UV spectro-
photometer at 260 nm. The encapsulation efficiency 
(EE) was calculated using the following equation:   
EE = [(Total amount of pcDNA3.1-VP2 − Free 
amount of pcDNA3.1-VP2 in supernatant) / Total 
amount of pcDNA3.1-VP2] ×100 
Fish vaccination and IPNV challenge: Rainbow trout 
wheiting  3 g were orally immunized with feed 
pellets at 5% of body weight containing alginate 
microspheres and CS/TPP nanoparticles loaded with 
pcDNA3.1-VP2 (named Alg–pcDNAVP2  and CS/ 
TPP–pcDNAVP2, respectivly) in separate trial  
groups (each group  90 fish) at temperature 15ºC for 
90 days. 
Two groups of rainbow trout were immunized 
with vaccine impregnated feed pellets (containing 
alginate microspheres loaded with 10 and 25 µg of 
pcDNA3.1-VP2, and boosted 15 days later with the 
same amount of the plasmid. In control group, fish 
orally immunized with alginate microspheres 
containing 10 µg of the empty-plasmid (pcDNA3.1) 
and boosted 15 days later with the same amount of 
empty-plasmid. Furthermore, a same experiment 
was performed via CS/TPP nanoparticles loaded 
with pcDNA3.1-VP2 in three separate groups. 
Unvaccinated fish were used as negative controls. At 
30 days post vaccination, two subgroups of 15 fish 
form each group were challenged by IP injection of  
0.2 ml/ fish with IPNV at a concentration of 107 
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TCID50 mL-1. At day 45 post-challenge when fish 
did not exhibit clinical symptoms, three trout from 
each group were sacrificed by overexposure to clove 
oil, spleen and head kidney were removed for 
assessing of transcript change of IgT, IgM and 
IPNV-VP4 genes.  
Transcriptional changes of IgM, IgT and IPNV-VP4 
genes: RNA was extracted from 20 mg of the 
homogenized head kidney and spleen samples using 
ExgeneTM Viral DNA/RNA kit (GeneAll, Korea), 
and then cDNA was synthesis was carried out in a 
total volume of 25 μl from 5 μl of extracted RNA 
using HyperScriptTM First strand Synthesis Kit 
(GeneAll, Korea) according to the manufacturer 
instruction. 
Relative expression of  adaptive- immune genes 
(IgM and IgT), as well as the VP4 gene of IPNV,  as 
an indicator of viral replication, were quantified in 
duplicate for each cDNA sample on the Real-Time 
PCR detection system (Applied Biosystems) using 
SYBR Green qPCR Master Mix. Each reaction 
containing 12.5 μl 2xSYBR Green PCR Master Mix, 
200 nM of each primer 100 ng cDNA template and 
nuclease-free water up to final volume of 25 μl were 
incubated for 15 min at 95°C (1 cycle), followed by 
40 cycles at 95°C for 15 s, 59°C for 1 min. 
The melting curve of each amplicon was 
examined, and the expression of the target genes was 
corrected based on the endogenous control 
expression (EF-1 α) and calculated as fold change in 
relative expression according to the 2-ΔΔCt method 
(Livak and Schmittgen, 2001). Primers are listed in 
Table 1.  
Statistics analysis: Data were statistically analyzed 
by one-way analysis of variance (ANOVA) using 
SPSS package (SPSS 1998). Differences were 
considered statistically significant at P<0.05. 
 
Results 
The encapsulation efficiency of alginate sodium and 
CS/TPP to encapsulate pcDNA3.1-VP2 were 
determined and the results revealed a high 
encapsulation efficiencies with 87.8% and 84.2% of 
DNA binding with alginate sodium microspheres 
Figure 1. (A) Diagram of the pcDNA3.1 vector encoding VP2 genomic fragment of IPNV, and (B) the agarose gel (1%) of pcDNA-VP2 digested 
by Hind III and Xho I enzymes. 
Table 1. The primers used for the real-time quantitative RT-PCR. 
Genes  Acc. No FW-Primer (5’-3’) Rev-Primer (5’-3’) 
VP4 M18049.1 AGGAGATGACATGTGCTACACCG CCAGCGAATATTTTCTCCACCA 
IgM X65263.1 ACCTTAACCAGCCGAAAGGG TGTCCCATTGCTCCAGTCC 
IgT AY870265 AGCACCAGGGTGAAACCA GCGGTGGGTTCAGAGTCA 
EF-1 α AF498320 GATCCAGAAGGAGGTCACCA TTACGTTCGACCTTCCATCC 
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and CS/TPP nanoparticles, respectively. 
Furthermore, distribution of DNA vaccine in 
different tissues of vaccinated fish was determined 
by RT-PCR amplification of VP2 gene at 30 days 
post vaccination (data not shown).  
IPNV-VP4 gene transcription: The relative 
expression of VP4 gene was determined to detect the 
rate of IPNV replication or the viral load (Fig. 2). 
VP4 expression in the virus control group showed 
stronger expression in the kidney as approximately 
15 and 9 times greater than the infected fish that were 
vaccinated with 25 µg Alg–pcDNAVP2 and 25 µg 
CS/TPP–pcDNAVP2, respectivly. Morover, VP4 
expression in vaccinated fish with 25 µg of vaccines 
was around 3 times greater than 10 µg fish 
treatments. The results showed a significantly lower 
levels of the virus in the vaccinated fish 45 days post-
challenge (P<0.05). 
Adaptive immune-related genes (IgM and IgT) 
transcription: In frothy-five days post challenging 
fish with IPNV, the levels of IgM and IgT genes 
expression were examined in the kidney and spleen 
of the vaccinated fish (10 and 25 µg dose of 
pcDNA3.1-VP2) and the results are showed in 
Figure 3. Transcript of IgM and IgT genes in the 
virus control group was greater than vaccinated fish 
(around 2 times). However, the expression patterns 
were similar. Hence, the oral DNA vaccine did not 
increase the transcript of IgT and IgM genes above 
the levels showed in the virus control, but it showed 
a mimic of viral activity and was kept them at 
appreciable levels in all vaccinated groups especially 
that of IgT gene in vaccinated fish with 25 µg 
CS/TPP–pcDNAVP2. 
 
Discussion 
IPNV is the causal agent of an acute contagious 
disease particularly in young salmonids, with high 
morbidity and mortality, and establishes an 
asymptomatic carrier state in the survivors (Evensen, 
2008). In the present study, the relative expression of 
IgM and IgT genes, as well as the VP4 gene of IPNV 
were assessed in orally vaccinated rainbow trout 
with different dose of encapsulated pcDNA3.1-VP2 
DNA vaccine with CS/TPP nanoparticles and 
alginate sodium microsphere, 45 days post-challenge 
with IPNV. The results showed that fish of all 
treatments survived and displayed no clinical 
Figure 2. Relative expression of the IPNV-VP4 gene in the kidney and spleen of vaccinated and IPNV infected trout. Rainbow trout (n=90) orally 
immunized with alginate microspheres (A) and CS-TPP nanoparticles (B) containing 10 and 25 µg of pcDNA3.1-VP2 and boosted 15 days later 
with the same amount of vaccine. Fish orally immunized with alginate microspheres (A) or CS-TPP nanoparticles (B) containing 10 µg of the 
empty-plasmid and boosted 15 days later with the same amount of empty-plasmid, and unvaccinated fish were used as negative controls. At 30 
days post-vaccination two subgroups of 15 fish form each group were challenged by IP injection 0.2 ml/fish with IPNV at a concentration of 107 
TCID50 mL-1. Transcription of the VP4 gene was recorded in the kidney and spleen of both vaccinated and virus control fish at 45 days post-
challenge. Data are represented relative to EF1-a expression (2-ΔΔCT method; n=3). Different letters indicate significant differences between groups 
at P<0.05. 
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symptoms of disease. The transcript of IPNV-VP4 
gene in the control group was significantly higher 
than vaccinated fish suggesting that oral vaccination 
has decreased the viral load. Similarly in the other 
studies, oral DNA vaccination of fishes has reduced 
replication of different viral agents such as IPNV and 
IHNV (Marjara et al., 2011; Ballesteros et al., 2014; 
Ballesteros et al., 2015), suggesting different 
immune modulatory effects of the vaccine may result 
in the inhibition of the viral replication.  
The results showed that CS/TPP nanoparticles 
and alginate sodium microsphere effectively 
protected the constructed IPN DNA vaccine from 
degradation in the fish stomach. The results also 
showed that IgT and IgM genes are express-able in 
both vaccinated and virus control fish, but with more 
intensely in the control carrier fish. However, 
vaccination did not enhance the expression of IgM 
and IgT above the levels observed in the control 
carrier group, but it showed mimiced viral activity 
and contributes to maintain at the appreciable levels 
in all vaccinated groups suggesting the presence of 
Ig secreting cells, and confirming the vaccine 
activity and the gene response to oral stimulation of 
vaccine administration. However, it remains unclear 
what immune activity is being induced by the virus 
that persists in surviving fish or by the exogenous 
VP2 gene.  
In conclusion, the results showed that CS/TPP 
nanoparticles and alginate sodium microspheres 
loaded with pcDNA3.1-VP2 vaccine are able to 
reduce viral replication in the surviving fish after 
challenging with IPNV. Moreover, the constructed 
DNA vaccine did not enhance the expression of IgM 
Figure 3. Expression of adaptive immune-related genes of IgM and IgT in the kidney and spleen of rainbow trout orally vaccinated with Alg–
pcDNAVP2 (A and C) and CS/TPP–pcDNAVP2 (B and D) after challenging with IPNV as described in legend Figure 2. Different letters indicate 
significant differences between groups at P<0.05. 
358 
 
Soltani et al./ Transcription of adaptive-immune genes in DNA vaccinated trout against IPNV 
and IgT genes above the levels observed in the virus 
control carrier group but it shows mimics viral 
activity and contribute to keep them at appreciable 
levels in all vaccinated groups. Further works are in 
progress to assess the correlation between these 
genes and clinical efficacy of the vaccine in the same 
fish groups. 
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